Skip to main content
CLOSE

Charities

Close

Corporate and Commercial

Close

Employment and Immigration

Close

Fraud and Investigations

Close

Individuals

Close

Litigation

Close

Planning, Infrastructure and Regeneration

Close

Public Law

Close

Real Estate

Close

Restructuring and Insolvency

Close

Energy

Close

Entrepreneurs

Close

Private Wealth

Close

Real Estate

Close

Tech and Innovation

Close

Transport and Infrastructure

Close

Health Tech

Health tech and digital health are transforming the health sector and creating unprecedented opportunities

  • Contact us
Tech and Innovation

Today’s demands of a fluid, fast-paced technology industry, mean that businesses must remain technologically and operationally agile in order to survive and thrive in a hugely ambitious and competitive environment. Whilst we are seeing more and more disruptive technologies transforming the health care industry and presenting more opportunities, we are also witnessing many more challenges, while coping with problem that the law is often a few steps behind the latest technological development.

Our specialist lawyers, many of whom have spent time as in-house counsel for technology companies, are passionate about the opportunities and challenges faced by our clients at all stages of their life cycle. We can offer practical and realistic solutions to your transactional and protection requirements, and take a hands-on approach to disputes relating to rights infringements or breach of commercial contracts.

We can advise on:

  • Corporate
  • IP, copyright and trademark
  • Cloud computing
  • Data protection and privacy
  • E-commerce and online trading
  • Hardware
  • Information technology services
  • Licensing
  • Outsourcing
  • Procurement
  • Social media
  • Software

We have advised many health tech companies that are listed on the Main Market and AIM of the London Stock Exchange, including EKF Diagnostics, Novacyt, Summit Therapeutics, Trellus Health, Verici Dx, Source Bioscience and Renalytix AI.

AIM Timeline

Our corporate team has advised on over 10 transactions in the health tech sector for AIM listed companies, including five IPOs. You can see details of some of these in our AIM deal timeline here:

AIM Timeline

Corporate analysis carried out by LexisNexis UK reviewing IPO deal activity in the first half of 2021 has revealed that we are one of the firms instructed on the most deals in H1 2021.

In July 2021, we were ranked 3rd by the number of Health Care clients in Adviser Rankings’ Q3 Advisers Rankings Guide.

BUIDLING BETTER CASE STUDY

NOVACYT First Covid Test

Revenues at Novacyt increased by more than 20 times after the COVID-19 tests that they manufacture were one of the world’s first to be approved. The AIM-listed diagnostics company is listed in London and Paris and has a head office in Camberley, Surrey.

BUILDING BETTER – NOVACYT

""

Our Offices

London
One Bartholomew Close
London
EC1A 7BL

Cambridge
50/60 Station Road
Cambridge
CB1 2JH

Reading
The Anchorage, 34 Bridge Street
Reading RG1 2LU

Southampton
Grosvenor House, Grosvenor Square
Southampton SO15 2BE

 

Reading
The Anchorage, 34 Bridge Street
Reading RG1 2LU

Southampton
Grosvenor House, Grosvenor Square
Southampton SO15 2BE

  • Lexcel
  • CYBER ESSENTIALS PLUS

© BDB Pitmans 2022. One Bartholomew Close, London EC1A 7BL - T +44 (0)345 222 9222

Our Services

Charities
Corporate and Commercial
Employment and Immigration
Fraud and Investigations
Individuals
Litigation
Planning, Infrastructure and Regeneration
Public Law
Real Estate
Restructuring and Insolvency

Sectors and Groups

Private Wealth
Real Estate
Transport and Infrastructure